BioDelivery Sciences International, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

BDSI 8.02 -0.10 (-1.23%)
price chart
Why Shares in BioDelivery Sciences International, Inc. Burst Today
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced that the ...  Inside Trade
BioDelivery Sciences International (BDSI) Crumbles: Stock Falls 24.3%  Zacks.com
Perilous Reversal Watch: BioDelivery Sciences International (BDSI)
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products principally in the areas of pain management and addiction.
Stock Update: BioDelivery Sciences International, Inc. (NASDAQ:BDSI)  The Markets Daily
Analyst Update: Facebook, Inc., BioDelivery Sciences International, Inc., and ...
Analysts are weighing in today on social media titan Facebook Inc (NASDAQ:FB), pharmaceutical firm BioDelivery Sciences International, Inc. (NASDAQ:BDSI), and online analytics platform TrueCar Inc (NASDAQ:TRUE). Here's a quick look at today's ...
BioDelivery Sciences International Now Covered by FBR & Co. (BDSI)  Dakota Financial News
BioDelivery Sciences International PT Lowered to $16.00 (BDSI)  WKRB News
Analyst Focus: BioDelivery Sciences International, Inc. (NASDAQ:BDSI)
Analysts on the Street are expecting BioDelivery Sciences International, Inc. (NASDAQ:BDSI) to post an earnings per share number of $-0.2 for the quarter that ends on 2015-03-31.
Stocks in News: BlackBerry Ltd (NASDAQ:BBRY), BioDelivery Sciences ...  Stock Transcript
BioDelivery Sciences to Host Conference Call and Webcast of First Quarter 2015 ...
About BioDelivery Sciences International BioDelivery Sciences International, Inc. is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine.
BioDelivery Sciences International Inc.: BioDelivery Sciences to Host ...  The Wall Street Transcript
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) is Expected to Report ...
According to analysts, BioDelivery Sciences International, Inc. (NASDAQ:BDSI) is expected to report earnings per share for the current fiscal quarter of $-0.2.
BioDelivery Sciences Appoints Dr. Sarah DeRossett to Vice President of ...  PR Newswire (press release)
Zacks Rating Update On BioDelivery Sciences International, Inc.
Biodelivery Sciences International (NASDAQ:BDSI) has received a short term rating of hold from research analysts at Zacks with a rank of 3. The company has been rated an average of 1 by 6 Wall Street Analysts. 6 analysts have added the counter in their ...
Cantor Fitzgerald Initiates Coverage on BioDelivery Sciences International ...  Dakota Financial News
BioDelivery Sciences International Research Coverage Started at Cantor ...  The Legacy
Wall Street Has $19.428 Price Target on BioDelivery Sciences International ...
On a consensus basis, Wall Street sell-side analysts have a mean target price of $19.428 for BioDelivery Sciences International, Inc. (NASDAQ:BDSI). This number is based on the mean estimate from the 7 research firms that recently issued reports on the ...
Endo Pharmaceuticals and BioDelivery Sciences Announce Acceptance of NDA ...
DUBLIN and RALEIGH, N.C., Feb. 23, 2015 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), and BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that the U.S. Food ...
BioDelivery Sciences to Receive $10M from Endo Pharmaceuticals  Drug Discovery & Development
BioDelivery Sciences International (BDSI) Marked As A Dead Cat Bounce Stock
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Trade-Ideas LLC identified BioDelivery Sciences ...
Related articles »